Inovio Pharmaceuticals, Inc. (INO)

NCM – Real Time Price. Currency in USD

0.77

+0.00 (0.03%)

Market open: Aug 12, 2026, 1:50 PM EDT

0.77

-0.00 (-0.09%)

Previous after-hours: Aug 11, 2026, 7:48 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

65K

218K

832K

10M

Cost of goods sold

-3M

-4M

-5M

Gross Profit

-3M

Operating expenses (excl. COGS)

-84M

-111M

-133M

-279M

Operating Income

-87M

-114M

-135M

-274M

Non-operating income, total

109K

-3M

Pretax income

-85M

-107M

-135M

-278M

Equity in earnings

-2M

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-85M

-107M

-135M

-280M

Discontinued operations

Net income

-85M

-107M

-135M

-280M

Dilution adjustment

Preferred dividends

Inovio Pharmaceuticals, Inc. (INO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Inovio Pharmaceuticals, Inc. (INO)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Inovio Pharmaceuticals, Inc. (INO)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Inovio Pharmaceuticals, Inc. (INO)

Income Statement (Annual)

Income Statement (Annual)